References
- Balgobind BV, van den Heuvel-Eibrink MM, De Menezes RX et al. Evaluation of gene expression signatures predictive for cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Haematologica96(2), 221–230 (2010).
- Ross ME, Mahfouz R, Onciu M et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood104, 3679–3687 (2004).
- Valk PJ, Verhaak RG, Beijen MA et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med.350, 1617–1628 (2004).
- Yagi T, Morimoto A, Eguchi M et al. Identification of a gene expression signature associated with pediatric AML prognosis. Blood102, 1849–1856 (2003).
- Andersson A, Ritz C, Lindgren D. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia21, 1198–1203 (2007).
- Bullinger L, Dohner K, Bair E et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med.350, 1605–1616 (2004).
- Verhaak RG, Wouters BJ, Erpelinck CA et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica94, 131–134 (2009).
- Wade N. A decade later, genetic map yields few new cures. The New York Times 13 June 2010.
- Breems DA, Van Putten WL, De Greef GE et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J. Clin. Oncol.26, 4791–4797 (2008).
- Haferlach T, Kohlmann A, Wieczorek L et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia study group. J. Clin. Oncol.28, 2529–2537 (2010).
- Marcucci G, Mrózek K, Radmacher MD et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood96(2), 221–230 (2010).
- Skavland J, Jørgensen KM, Hadziavic K et al. Specific cellular signal transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia. Blood Cancer J.1, e4 (2011).
- Gentles AJ, Plevritis SK, Majeti R, Alizadeh AA. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA304, 2706–2715 (2010).